Drug Shortage Report for TEVA-CARBAMAZEPINE

Last updated on 2019-12-19 History
Report ID 86859
Drug Identification Number 00782718
Brand name TEVA-CARBAMAZEPINE
Common or Proper name CARBAMAZEPINE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CARBAMAZEPINE
Strength(s) 200MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code N03AF
ATC description ANTIEPILEPTICS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-06-18
Estimated end date 2019-12-31
Actual end date 2019-12-18
Shortage status Resolved
Updated date 2019-12-19
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2019-12-19 French Compare
v18 2019-12-19 English Compare
v17 2019-11-21 French Compare
v16 2019-11-21 English Compare
v15 2019-11-14 French Compare
v14 2019-11-14 English Compare
v13 2019-11-14 French Compare
v12 2019-11-14 English Compare
v11 2019-09-19 French Compare
v10 2019-09-19 English Compare
v9 2019-08-22 French Compare
v8 2019-08-22 English Compare
v7 2019-08-06 French Compare
v6 2019-08-06 English Compare
v5 2019-06-27 French Compare
v4 2019-06-27 English Compare
v3 2019-06-19 English Compare
v2 2019-06-18 French Compare
v1 2019-06-18 English Compare

Showing 1 to 19 of 19